InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Browse the detailed record of transactions filed by Simon, Christopher, Chairman & CEO. Director active across 2 companies, notably HAEMONETICS CORP. Cumulatively, 11 disclosures have been logged. Total volume traded: €705k. The latest transaction was disclosed on 13 June 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations11 total
€69,0001,148 shares@ €60.10480.0026% mcap14.4% of flow
Common Stock
SEC:0001127602-22-017539:0·
€139,4402,496 shares@ €55.86550.0053% mcap29.1% of flow
Common Stock
SEC:0001127602-22-015375:0·
€44,713832 shares@ €53.7410.0017% mcap9.3% of flow
Common Stock
SEC:0001127602-22-014951:0·
€59,2661,200 shares@ €49.38860.0019% mcap26.2% of flow
Common Stock
SEC:0001127602-21-020048·
€59,2661,200 shares@ €49.38860.0023% mcap12.4% of flow
Common Stock
SEC:0001127602-21-020048:0·
€122,6622,715 shares@ €45.17930.0040% mcap54.3% of flow
Common Stock
SEC:0001127602-21-019521·
€122,6622,715 shares@ €45.17930.0047% mcap25.6% of flow
Common Stock
SEC:0001127602-21-019521:0·
26,515 shares
Common Stock
SEC:0001127602-21-017675·
26,515 shares
Common Stock
SEC:0001127602-21-017675:0·
€44,014956 shares@ €46.03980.0014% mcap19.5% of flow
Common Stock
SEC:0001127602-21-017256·
€44,014956 shares@ €46.03980.0017% mcap9.2% of flow
Common Stock
SEC:0001127602-21-017256:0·
11 of 11 declarations
About Simon, Christopher
Christopher Simon is President & CEO of Haemonetics Corp. He leads the company with a focus on innovation and improving healthcare. His role involves overseeing operations and implementing strategy to ensure the growth and competitiveness of the organization.
